Windlas Biotech Ltd
NSE:WINDLAS

Watchlist Manager
Windlas Biotech Ltd Logo
Windlas Biotech Ltd
NSE:WINDLAS
Watchlist
Price: 814.45 INR -4.53% Market Closed
Market Cap: 17.2B INR

Operating Margin

9%
Current
Declining
by 0.4%
vs 3-y average of 9.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9%
=
Operating Income
₹749.4m
/
Revenue
₹8.3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9%
=
Operating Income
₹749.4m
/
Revenue
₹8.3B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Windlas Biotech Ltd
NSE:WINDLAS
17B INR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
233.6B USD
Loading...
US
Danaher Corp
NYSE:DHR
166.7B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
89T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.1B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
284.5B CNY
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.8B USD
Loading...
US
Waters Corp
NYSE:WAT
23.1B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in India
Percentile
57th
Based on 5 437 companies
57th percentile
9%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Windlas Biotech Ltd
Glance View

Windlas Biotech Ltd. operates as a contract development and manufacturing organization (CDMO). The firm provides a range of contract development and manufacturing organization (CDMO) services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics. Its therapeutic categories, such as, anti-diabetic, cardiovascular, neuropsychiatry and respiratory therapies. The Company’s service capabilities include formulation development, technology scale-up and full-scale commercial manufacturing. The company has capabilities for both solid and liquid pharmaceutical dosage forms. The Company’s market its own manufactured nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities. The company also has a salesforce and distribution network spread across over 14 states. The Company’s manufacturing facilities are located at Dehradun in Uttarakhand.

WINDLAS Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
9%
=
Operating Income
₹749.4m
/
Revenue
₹8.3B
What is Windlas Biotech Ltd's current Operating Margin?

The current Operating Margin for Windlas Biotech Ltd is 9%, which is below its 3-year median of 9.4%.

How has Operating Margin changed over time?

Over the last 3 years, Windlas Biotech Ltd’s Operating Margin has decreased from 9.1% to 9%. During this period, it reached a low of 8.8% on Mar 31, 2025 and a high of 10.3% on Mar 31, 2024.

Back to Top